Houston Methodist Emerging Topics in Liver Disease Conference 2025

Videos

The epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.

September 20, 2025 6:00pm – Sunday, September 21, 2025

This activity will provide lecture format presentations, debate and panel discussions, Q&A sessions and case discussions.

• Drug-Induced Liver Injury in the Patient with Chronic Liver Disease

• Management of Coagulopathy & Bleeding Diathesis in Cirrhosis

• From Risk to Recognition: Addressing Emerging Threats to Improve Prevention and Detection of HCC

• Unique Complications of Portal Hypertension (Panel Q&A)

• Endocrine Aspects of MASLD & Obesity: 2025 Update

• Noninvasive Assessment of Fibrosis in MASLD

• Current and Future Treatment Options of MASLD

• The Patient with MASLD and Concomitant Alcohol-Associated Liver Disease, HBV, or HCV – What to Do?

• Advances in MASLD – What’s New? (Panel Q&A)

• The Future of Liver Transplantation in 2025

• Role of Artificial Intelligence (AI) in the Management of Liver Disease

• Living Donor Liver Transplant – A New Era

• The Role of Liver Transplantation in the Management of Cholangiocarcinoma

• Current Innovations in Liver Disease (Panel Q&A)

• Surveillance & Diagnosis of Hepatocellular Cancer – What Is New?

• Management of Hepatocellular Carcinoma – Role of Immunotherapy

• Expanding Role of Transplantation for Rare and Not-So-Rare Tumors

• Liver Cancer – Current Concepts (Panel Q&A)